Thanks again for taking time to explain in details. I have no issue whether RSPI ink any deal with any of the big pharmaceuticals whether it is in U.S or abroad. As long people in general can benefits from RSPI drugs, it is always a good thing to serve as many people as possible. Also, agree with you about the lengthy and delayed processes to approve anything in U.S. Big Pharmas don't let that happen easily. They don't want any new small companies to succeed. They always try to kill them using their big pockets.
I am just hoping to see RSPI comes out of EM soon and trades at its fair value for all its pipeline assets. Waiting patiently for that to come.
Market Data 
Markets 
AI
